Cargando…

Aquaporin-8 ameliorates hepatic steatosis through farnesoid X receptor in obese mice

Aquaporin-8(AQP8), is a transmembrane channel protein that abounds in liver, which mainly promotes water transport, modulating bile acid formation. However, its role in hepatic lipid metabolism remains unclear. In this study, we found the expression of AQP8 was reduced in liver specimens of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Minqi, Qian, Xu, Han, Luyu, Wang, Hui, Wang, Jiqiu, Liu, Weiren, Gu, Yanyun, Yao, Shuangshuang, Yang, Jian, Zhang, Yifei, Peng, Ying, Zhang, Zhiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130924/
https://www.ncbi.nlm.nih.gov/pubmed/37123234
http://dx.doi.org/10.1016/j.isci.2023.106561
Descripción
Sumario:Aquaporin-8(AQP8), is a transmembrane channel protein that abounds in liver, which mainly promotes water transport, modulating bile acid formation. However, its role in hepatic lipid metabolism remains unclear. In this study, we found the expression of AQP8 was reduced in liver specimens of patients with NAFLD, high-fat diet (HFD)-induced mice and genetically obese db/db mice. Knockdown of AQP8 in hepatocytes exacerbated the intracellular lipid accumulation induced by free fatty acid (FFA) mixtures. In contrast, hepatic AQP8 overexpression activated farnesoid X receptor (FXR), inhibiting gene expression associated with lipogenesis, which further reduced intrahepatic triglyceride overload in obese mice. FXR knockout abrogated the ameliorating effect of AQP8 overexpression on NAFLD in mice. These findings indicate that AQP8 overexpression protects against fatty liver through activating the FXR pathway.